Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Lenalidomide may stop the growth of multiple myeloma by blocking blood flow to the
cancer. Drugs used in chemotherapy, such as cyclophosphamide and dexamethasone, work in
different ways to stop the growth of cancer cells, either by killing the cells or by stopping
them from dividing. Giving lenalidomide together with cyclophosphamide and dexamethasone may
kill more cancer cells.> PURPOSE: This phase II trial is studying how well giving
lenalidomide together with cyclophosphamide and dexamethasone works in treating patients with
newly diagnosed multiple myeloma.